The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

A few weeks after releasing disappointing data from its norovirus vaccine trial, a Boston biotech is cutting its workforce. A few weeks after releasing disappointing data from its norovirus ...

“Lots of companies are limping along,” said Mani Foroohar, senior research analyst at Boston health care investment bank Leerink Partners. Foroohar, a top biotech analyst, has slapped an ...

The entrepreneur says biotech should be less contentious than AI, as a breakthrough in Beijing is just as usable in Boston ...

A Nurturing Force in Boston's Biotech Ecosystem Cambridge Scientific has emerged as a trusted partner in the region's booming biotech industry. Founded in 1997 by CEO Barb Pearlman, the company's ...

In late 2021, bioengineer Jason Kelly became a billionaire for, as he put it, “a hot minute”. Investors in Ginkgo Bioworks Holdings, the Boston company he co-founded, had driven its market ...

A Cambridge-based pharmaceutical company is laying off close to a hundred ... The post Pharma company announces it will lay off 83 Boston-area employees appeared first on Boston.com.

A new era of medical science is taking shape in Massachusetts. Our biotech companies are at work on a gene therapy that can cure deafness, treatments that slow the effects of aging, and a ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

In August, a single email triggered a chain of hand-wringing and strategizing inside one of America’s largest medical technology companies: A reporter asked Boston Scientific if the biotech ...

Chicago’s life sciences market is the smallest of any major U.S. market by square footage yet has a vacancy rate of 43.3 ...